외용 항진균제 시장 보고서(2026년)
Topical Antifungals Global Market Report 2026
상품코드 : 1957874
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,822,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,861,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,900,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

외용 항진균제 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 60억 2,000만 달러에서 2026년에는 64억 2,000만 달러에 이르고, CAGR 6.7%로 성장할 전망입니다. 지난 수년간의 성장 요인으로는 외용 항진균제 선택의 제한, 피부사상균 감염의 높은 발생률, 병원 약국 의존도, 곰팡이 감염에 대한 소비자의 낮은 인식, 기존 제형에 대한 선호도 등을 꼽을 수 있습니다.

외용 항진균제 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 82억 3,000만 달러에 이르고, CAGR은 6.4%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 아졸계 및 알릴아민계 약물의 혁신적인 개발, 헬스케어 영역의 보급 확대, 온라인 약국 플랫폼의 성장, 크림 및 스프레이 등 환자 친화적인 제형에 대한 수요 증가, 제약사의 피부과 영역 투자 확대 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 피부 진균 감염의 유병률 증가, 전신 치료보다 외용제 선호도 증가, 새로운 제형 및 전달 시스템 개발, 재택치료 및 자가 치료 인식 증가, 온라인 약국 및 전자상거래 유통 채널의 확대 등이 있습니다.

피부 질환 증가 추세는 향후 몇 년 동안 외용 항진균제 시장의 성장을 견인할 것으로 예측됩니다. 피부질환이란 피부의 건강 상태, 외관, 기능에 영향을 미치는 병태로 자극, 염증, 감염 등이 포함됩니다. 피부질환 증가는 주로 환경오염물질과 자외선(UV)에 대한 노출 증가에 기인하며, 이는 피부를 손상시켜 다양한 피부질환을 유발할 수 있습니다. 외용 항진균제는 곰팡이 병원균에 대한 표적화된 작용을 통해 전신 노출을 제한하고 부작용의 위험을 줄이며 환부의 치유를 촉진하기 위해 피부 질환을 치료하는 데 사용됩니다. 예를 들어, 2023년 3월 스위스에 본부를 둔 국제기구인 세계보건기구(WHO)가 발표한 데이터에 따르면, 피부질환은 전 세계적으로 약 18억 명에게 지속적으로 영향을 미치는 것으로 추산됩니다. 따라서 피부질환 증가 추세가 외용 항진균제 시장의 성장을 견인하고 있습니다.

외용 항진균제 시장에서 사업을 전개하는 주요 기업들은 치료 효과 향상, 항진균제 내성 해결, 손발톱 백선 치료를 위한 손발톱 층 침투성 향상을 목적으로 히스톤 탈아세틸화 효소(HDAC) 억제제 등 혁신적인 제제 개발에 주력하고 있습니다. HDAC 억제제는 히스톤 단백질에서 아세틸기를 제거하는 역할을 하는 히스톤 탈아세틸화 효소를 억제하는 화합물입니다. 예를 들어, 2024년 1월, 미국 소재 생명공학 기업 반다 파마슈티컬스(Vanda Pharmaceuticals)는 광범위한 조진균증인 손발톱 백선 치료제로 VTR-297을 평가하기 위한 임상시험계획(IND)을 미국 식품의약국(FDA)으로부터 승인받았습니다. VTR-297은 항진균 특성을 가진 저분자 HDAC 억제제로, 원래 방선균의 일종인 Streptomyces hygroscopicus에서 분리되어 처음에는 항진균성 항생제로 확인되었습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

LSH
영문 목차

영문목차

Topical antifungals are medications applied externally to treat fungal infections affecting the skin, nails, or mucosal surfaces by inhibiting fungal growth or eliminating the fungi. They are typically used for mild to moderate infections and help reduce symptoms such as itching, redness, and inflammation.

The main product types of topical antifungals include azoles, allylamines, echinocandins, and polyenes. Azoles act by blocking the synthesis of ergosterol, an essential component of fungal cell membranes. These drugs are available in various formulations, including creams, ointments, lotions, sprays, and powders. They are mainly used to manage conditions such as dermatophyte infections, candidiasis, tinea infections, and onychomycosis. Topical antifungals are distributed through multiple channels, including pharmacies, online pharmacies, hospital pharmacies, and drugstores, and are utilized by end users such as hospitals, clinics, home healthcare settings, and pharmaceutical companies.

Tariffs have affected the topical antifungals market by increasing the cost of imported active pharmaceutical ingredients (APIs) and raw materials used in creams, ointments, and sprays. Segments such as azoles and allylamines are particularly impacted, with regions like Asia-Pacific, including India and China, facing higher import duties. This has led to increased production costs and pricing adjustments across pharmacies and hospitals. However, tariffs have also encouraged local manufacturing, boosting domestic API production and innovation in cost-effective formulations.

The topical antifungals market research report is one of a series of new reports from The Business Research Company that provides topical antifungals market statistics, including topical antifungals industry global market size, regional shares, competitors with a topical antifungals market share, detailed topical antifungals market segments, market trends and opportunities, and any further data you may need to thrive in the topical antifungals industry. This topical antifungals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The topical antifungals market size has grown strongly in recent years. It will grow from $6.02 billion in 2025 to $6.42 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to limited topical antifungal options, high incidence of dermatophyte infections, reliance on hospital pharmacies, low consumer awareness of fungal infections, preference for conventional formulations.

The topical antifungals market size is expected to see strong growth in the next few years. It will grow to $8.23 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to development of azoles and allylamines innovations, increasing home healthcare adoption, growth of online pharmacy platforms, rising demand for patient-friendly formulations like creams and sprays, expansion of pharmaceutical company investments in dermatology. Major trends in the forecast period include rising prevalence of skin fungal infections, increasing preference for topical over systemic treatments, development of novel formulations and delivery systems, growing awareness of home healthcare and self-medication, expansion of online pharmacies and e-commerce distribution channels.

The increasing prevalence of skin diseases is expected to drive the growth of the topical antifungals market in the coming years. Skin diseases are conditions that affect the skin's health, appearance, or function, including irritation, inflammation, and infections. The rise in skin diseases is largely attributed to greater exposure to environmental pollutants and ultraviolet (UV) radiation, which can damage the skin and trigger various dermatological conditions. Topical antifungals are used in the treatment of skin diseases as they deliver targeted action against fungal pathogens, limit systemic exposure, reduce the risk of side effects, and support faster healing of affected areas. For example, in March 2023, according to the World Health Organization, a Switzerland-based health organization, skin conditions were estimated to affect around 1.8 billion people globally at any given time. Therefore, the growing prevalence of skin diseases is driving the growth of the topical antifungals market.

Major companies operating in the topical antifungals market are focusing on developing innovative formulations, such as histone deacetylase (HDAC) inhibitors, to improve therapeutic effectiveness, address antifungal resistance, and enhance penetration into the nail bed for the treatment of onychomycosis. HDAC inhibitors are compounds that inhibit histone deacetylase enzymes, which are responsible for removing acetyl groups from histone proteins. For instance, in January 2024, Vanda Pharmaceuticals Inc., a US-based biotechnology company, received approval from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to evaluate VTR-297 for the treatment of onychomycosis, a widespread fungal nail infection. VTR-297 is a small-molecule HDAC inhibitor with antifungal properties, originally isolated from the bacterial species Streptomyces hygroscopicus and initially identified as an antifungal antibiotic.

In January 2023, Eris Lifesciences Ltd., an India-based pharmaceutical company focused on branded formulations, acquired nine dermatology brands, including topical antifungals such as Onabet and Luligee, from Glenmark Pharmaceuticals Ltd. for an undisclosed sum. Through this acquisition, Eris Lifesciences aims to strengthen its dermatology portfolio, expand its chronic therapy offerings, and accelerate growth in high-potential skin treatment segments. Glenmark Pharmaceuticals Ltd. is an India-based pharmaceutical company involved in the development and commercialization of generic formulations, specialty drugs, and active pharmaceutical ingredients.

Major companies operating in the topical antifungals market are Pfizer Inc., Bayer AG, Novartis AG, GSK plc, Macleods Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Galderma S.A., Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Cipla Limited, Lupin Limited, Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ipca Laboratories Ltd., Taro Pharmaceutical Industries Ltd., Natco Pharma Ltd., Glamris Dermacare, Perrigo Company plc, Teva Pharmaceutical Industries Ltd., Viatris Inc., Amneal Pharmaceuticals LLC, Torrent Pharmaceuticals Ltd., Abbott Laboratories, Johnson & Johnson (Janssen Consumer Health), Reckitt Benckiser Group plc, Himalaya Wellness Company, Aristo Pharmaceuticals Pvt. Ltd., Emcure Pharmaceuticals Ltd., Ajanta Pharma Ltd., Alembic Pharmaceuticals Ltd.

North America was the largest region in the topical antifungals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the topical antifungals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the topical antifungals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The topical antifungals market consists of sales of clotrimazole, terbinafine, ketoconazole, econazole, and tolnaftate. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Topical Antifungals Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses topical antifungals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for topical antifungals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The topical antifungals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Topical Antifungals Market Characteristics

3. Topical Antifungals Market Supply Chain Analysis

4. Global Topical Antifungals Market Trends And Strategies

5. Topical Antifungals Market Analysis Of End Use Industries

6. Topical Antifungals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Topical Antifungals Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Topical Antifungals Total Addressable Market (TAM) Analysis for the Market

9. Topical Antifungals Market Segmentation

10. Topical Antifungals Market Regional And Country Analysis

11. Asia-Pacific Topical Antifungals Market

12. China Topical Antifungals Market

13. India Topical Antifungals Market

14. Japan Topical Antifungals Market

15. Australia Topical Antifungals Market

16. Indonesia Topical Antifungals Market

17. South Korea Topical Antifungals Market

18. Taiwan Topical Antifungals Market

19. South East Asia Topical Antifungals Market

20. Western Europe Topical Antifungals Market

21. UK Topical Antifungals Market

22. Germany Topical Antifungals Market

23. France Topical Antifungals Market

24. Italy Topical Antifungals Market

25. Spain Topical Antifungals Market

26. Eastern Europe Topical Antifungals Market

27. Russia Topical Antifungals Market

28. North America Topical Antifungals Market

29. USA Topical Antifungals Market

30. Canada Topical Antifungals Market

31. South America Topical Antifungals Market

32. Brazil Topical Antifungals Market

33. Middle East Topical Antifungals Market

34. Africa Topical Antifungals Market

35. Topical Antifungals Market Regulatory and Investment Landscape

36. Topical Antifungals Market Competitive Landscape And Company Profiles

37. Topical Antifungals Market Other Major And Innovative Companies

38. Global Topical Antifungals Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Topical Antifungals Market

40. Topical Antifungals Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기